Synthesis and Antiviral Activities of 3-Aralkyl-Thiomethylimidazo[1,2-<i>b</i>]Pyridazine Derivatives
Article 2003 en
Authors
CG
Christophe Galtier
SM
Sylvie Mavel
RS
Robert Snoeck
Abstract
1 min read
The synthesis of novel substituted 3-aralkylthiomethylimidazo[1,2-b]pyridazines is reported. All of the synthesized compounds are devoid of antiviral activity against the replication of human immunodeficiency virus. However, compounds 6-chloro-8-methyl-3-phenethylthioimidazo[1,2-b]pyridazine and 6-chloro-2-methyl-3-phenethylthioimidazo[1,2-b]pyridazine are potent inhibitors of the replication of human cytomegalovirus in vitro, while compounds 6-chloro-2-methyl-3-benzylthiomethylimidazo[1,2-b]pyridazine and 6-chloro-2-methyl-3-phenethyl-thioimidazo[1,2-b]pyridazineare inhibitors of the replication of varicella-zoster virus. The results presented here suggest that compound 10 should be considered as a new lead in the development of antiviral agents.
Alain Gueiffier, Sylvie Mavel, Mohammed Lhassani, Ahmed Elhakmaoui, Robert Snoeck, Graciela Andreï, Olivier Chavignon, Jean‐Claude Teulade, Myriam Witvrouw, Jan Balzarini, De Clercq Erik, Jean‐Pierre Chapat
Marcela Krečmerová, Antonı́n Holý, A. Pískala, Milena Masojı́dková, Graciela Andreï, Lieve Naesens, Johan Neyts, Jan Balzarini, De Clercq Erik, Robert Snoeck
Discussion(0)
No comments yet. Be the first to comment.